ACADIA Pharmaceuticals, Inc. (ACAD)
18.14
-0.23
(-1.25%)
USD |
NASDAQ |
Nov 12, 16:00
18.12
-0.02
(-0.08%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap : 3.134B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 3.134B |
| November 11, 2026 | 3.174B |
| November 10, 2026 | 3.159B |
| November 09, 2026 | 2.851B |
| November 06, 2026 | 3.668B |
| November 05, 2026 | 3.670B |
| November 04, 2026 | 3.710B |
| November 03, 2026 | 3.554B |
| November 02, 2026 | 3.524B |
| October 30, 2026 | 3.544B |
| October 29, 2026 | 3.573B |
| October 28, 2026 | 3.498B |
| October 27, 2026 | 3.472B |
| October 26, 2026 | 3.398B |
| October 23, 2026 | 3.396B |
| October 22, 2026 | 3.496B |
| October 21, 2026 | 3.475B |
| October 20, 2026 | 3.518B |
| October 19, 2026 | 3.408B |
| October 16, 2026 | 3.291B |
| October 15, 2026 | 3.393B |
| October 14, 2026 | 3.314B |
| October 13, 2026 | 3.205B |
| October 12, 2026 | 3.341B |
| October 09, 2026 | 3.405B |
| Date | Value |
|---|---|
| October 08, 2026 | 3.370B |
| October 07, 2026 | 3.382B |
| October 06, 2026 | 3.398B |
| October 05, 2026 | 3.462B |
| October 02, 2026 | 3.434B |
| October 01, 2026 | 3.424B |
| September 30, 2026 | 3.468B |
| September 29, 2026 | 3.481B |
| September 28, 2026 | 3.534B |
| September 25, 2026 | 3.560B |
| September 24, 2026 | 3.818B |
| September 23, 2026 | 4.377B |
| September 22, 2026 | 4.546B |
| September 21, 2026 | 4.543B |
| September 18, 2026 | 4.697B |
| September 17, 2026 | 4.725B |
| September 16, 2026 | 4.741B |
| September 15, 2026 | 4.606B |
| September 14, 2026 | 4.737B |
| September 11, 2026 | 4.790B |
| September 10, 2026 | 4.775B |
| September 09, 2026 | 4.765B |
| September 08, 2026 | 4.747B |
| September 04, 2026 | 4.823B |
| September 03, 2026 | 4.796B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 4.545B |
| Arcturus Therapeutics Holdings, Inc. | 240.21M |
| ADMA Biologics, Inc. | 2.950B |
| Immunic, Inc. | 106.29M |
| Viking Therapeutics, Inc. | 3.517B |
Market Cap Related Metrics
| PE Ratio | 8.618 |
| PS Ratio | 2.612 |
| PEG Ratio | 0.2433 |
| Price to Book Value | 2.259 |
| Price to Free Cash Flow | 38.30 |
| Price | 18.14 |
| Earnings Yield | 11.60% |
| PEGY Ratio | 0.2433 |
| Operating PE Ratio | 25.67 |
| Normalized PE Ratio | 8.618 |